Loading...
Catalyst Pharmaceuticals, Inc.
CPRX•NASDAQ
HealthcareBiotechnology
$23.65
$-0.18(-0.76%)
Catalyst Pharmaceuticals, Inc. (CPRX) AI-Powered Stock Analysis
See how Catalyst Pharmaceuticals, Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerCatalyst Pharmaceuticals, Inc. (CPRX) Stock Overall Grade
Catalyst Pharmaceuticals, Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
A
Good
Grade Breakdown by Metric
See how each financial and market factor contributes to Catalyst Pharmaceuticals, Inc.'s overall stock rating.
Forecast
B+Score
79/100Financial Growth
A+Score
100/100Fundamental Growth
B+Score
70/100Key Ratios
A+Score
97/100Sector Comparison
B+Score
75/100Industry Comparison
B+Score
75/100S&P 500 Benchmark
AScore
85/100Analyst Consensus
B+Score
75/100Component Analysis Explained
Understand the key factors behind each Catalyst Pharmaceuticals, Inc. stock grade, including financials, comparisons, and forecasts.